Visualizing GSH-ONOO- Redox and Tracking Lesion-Remedy of Acute Kidney Oxidative Injury Based on a Dual-Site

Meili Yang1,2, Zuzhe Kang2, Xinpei Zhong2

  • 1Shaanxi Key Laboratory of Phytochemistry, College of Chemistry and Chemical Engineering, Baoji University of Arts and Sciences, Baoji, 721013, China.

PubMed

Insights

A new fluorescent sensor, BPS, enables real-time monitoring of peroxynitrite (ONOO-) and glutathione (GSH) to track drug-induced acute kidney injury (DIAKI) and its treatment. This tool aids in understanding oxidative stress in kidney disease.

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Toxicology

Background:

  • Drug-induced acute kidney injury (DIAKI) is a critical clinical issue linked to peroxynitrite (ONOO-) accumulation and glutathione (GSH) depletion.
  • Current diagnostic and therapeutic strategies for DIAKI are challenged by the lack of effective real-time nephrotoxicity monitoring methods.
  • Oxidative stress plays a significant role in the pathogenesis of DIAKI, highlighting the need for tools to track key redox species.

Purpose of the Study:

  • To develop a novel dual-site fluorescent chemosensor (BPS) for simultaneous, real-time monitoring of ONOO- and GSH.
  • To investigate the potential of BPS in tracking the progression and treatment of cisplatin-induced DIAKI in cellular and animal models.
  • To provide a new strategy for visualizing and modulating intracellular redox balance in the context of kidney injury.

Main Methods:

  • Development of a dual-site fluorescent chemosensor, BPS, with distinct excitation and emission channels for ONOO- and GSH.
  • Characterization of BPS for sensitivity, specificity, and anti-interference capabilities against ONOO- and GSH.
  • Application of BPS for in vivo and in vitro monitoring of ONOO-/GSH levels during cisplatin-induced DIAKI and subsequent treatment in mice and HK-2 cells.

Main Results:

  • The BPS sensor successfully achieved simultaneous real-time monitoring of ONOO- and GSH without spectral crosstalk.
  • BPS demonstrated high sensitivity (181 nM for ONOO-, 2.42 µM for GSH), specificity, and anti-interference properties.
  • Real-time tracking of ONOO-/GSH dynamics in cisplatin-induced DIAKI models confirmed the sensor's utility in disease progression and remedy monitoring.

Conclusions:

  • The developed BPS chemosensor offers a feasible tool for investigating oxidative stress-related DIAKI disease processes.
  • BPS enables real-time visualization and modulation of intracellular GSH/ONOO- redox balance, advancing our understanding of kidney injury mechanisms.
  • This study presents a novel strategy for monitoring and potentially managing redox imbalances in DIAKI and related conditions.